News

Filter

Current filters:

Krystexxa

1 to 9 of 11 results

Savient files for voluntary bankruptcy protection; plans asset sale

15-10-2013

US drugmaker Savient Pharmaceuticals says it has elected to file voluntary petitions under Chapter 11…

FinancialKrystexxaMergers & AcquisitionsPharmaceuticalSavient Pharmaceuticals

Savient's Krystexxa gets final EU approval for chronic tophaceous gout

10-01-2013

US drugmaker Savient Pharmaceuticals (Nasdaq: SVNT) says that the European Commission has granted a marketing…

EuropeInflammatory diseasesKrystexxaPharmaceuticalRegulationSavient Pharmaceuticals

Chelsea Therapeutics and Savient to slash jobs

11-07-2012

Chelsea Therapeutics International (Nasdaq: CHTP) yesterday announced restructuring plans to "significantly…

BiotechnologyChelsea TherapeuticsFinancialKrystexxaManagementNortheraSavient Pharmaceuticals

1 to 9 of 11 results

COMPANY SPOTLIGHT

Menarini

Back to top